Condition

SCLC, Limited Stage clinical trials and research

• 6Clinical trials
• 1Country

Newest SCLC, Limited Stage clinical trials

All recruiting trials (6)

• Tislelizumab plus Anlotinib after chemoradiotherapy in limited-stage SCLC

  This phase II trial tests whether adding tislelizumab and anlotinib after chemoradiotherapy helps people with limited-stage small cell lung cancer stay cancer-free.

  Recruiting Phase 2 Yantai Yuhuangding Hospital · Yantai, Shandong · NCT07815223

• Adebrelimab consolidation after chemoradiotherapy for limited-stage small-cell lung cancer

  This study tests whether adding adebrelimab after chemoradiotherapy helps patients with untreated limited-stage small-cell lung cancer see better outcomes.

  Recruiting Phase 2 Henan Cancer Hospital · Zhengzhou, Henan and 1 other locations · NCT07559786

• Using a new PFD3 PET tracer to find and stage small cell lung cancer

  This test will try a new PET tracer called PFD3 in adults with small cell lung cancer to see if it detects tumors and stages disease more accurately than standard FDG PET/CT.

  Recruiting Phase 1/2 Peking University First Hospital · Beijing, Beijing Municipality · NCT07508852

• Skipping the clinical target volume (CTV) around the primary tumor in limited-stage small cell lung cancer

  This trial tests whether giving chest radiotherapy that skips the usual extra margin around the main tumor is as effective and causes fewer side effects for people with limited-stage small cell lung cancer who have responded to initial chemotherapy.

  Recruiting at 2 sites Phase 3 Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07008716

• Combining Serplulimab with Chemotherapy for Early-stage Small Cell Lung Cancer

  This study is testing if combining a new drug called serplulimab with chemotherapy can help people with early-stage small cell lung cancer before surgery.

  Recruiting Phase 2 Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT06911606

• Combining Durvalumab with Chemoradiotherapy for Limited Stage Small Cell Lung Cancer

  This study is testing if adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can help people with limited stage small cell lung cancer live longer and feel better.

  Recruiting Phase 2 Hebei Medical University Fourth Hospital · Shijiazhuang, Hebei · NCT06371482

Related topics

Quick answers

How many SCLC, Limited Stage clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →